Positron Corp (POSC) stock
Close on Oct 19, 2026Market cap $55.84MP/E –Yield –
Positron Corp saw revenue fall 21.5% to $461.45K over fiscal 2025. At the latest close the market valued the company at $55.84M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $55.84M
- P/E ratio
- –
- Price to sales
- 121.02
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $461.45K
- Net income
- -$10.60M
- EPS, diluted
- -$0.34
- Book value per share
- -$0.02
- Diluted shares
- 33M
Trading
- Previous close
- $1.55
- Open
- $1.69
- Day's range
- $1.63 – $1.70
- Volume
- 13,445
- Average volume (20 days)
- 24,537
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | POSC | S&P 500 | Difference | POSC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -3.0% | +0.6% | −3.6 pts | ||
| 3 months | +3.0% | +3.4% | −0.3 pts | ||
| Year to date | +1.8% | +13.3% | −11.5 pts | ||
| 1 year | +22.9% | +16.6% | +6.2 pts | ||
| 3 years | +18.2% | +86.4% | −68.2 pts | +5.7% | +23.1% |
| 5 years | +209.1% | +81.9% | +127.2 pts | +25.3% | +12.7% |
| 10 years | +5762.1% | +318.9% | +5443.2 pts | +50.2% | +15.4% |
Nine years at a glance
Fiscal years 2009 to 2025, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
About Positron
Electromedical & Electrotherapeutic Apparatus
Positron Corporation is a medical technology company that co-develops, manufactures, and sells positron emission tomography (PET) and PET-computed tomography (PET-CT) imaging systems. The company specializes in cardiac PET imaging for the diagnosis and management of cardiovascular disease, while expanding its applications into oncology and neurology. Key offerings include its dedicated PET systems, the Affinity PET-CT 4D 64-slice system, and related cardiac-focused software. Positron provides clinical, training, remote diagnostic, and maintenance services, along with flexible commercial arrangements such as rentals and service contracts. Its customers primarily include hospitals, outpatient imaging centers, and cardiology practices.
Company profile, executives and historyPositron stock: common questions
What is Positron's stock price?
POSC closed at $1.70 on Oct 19, 2026, up 9.68% on the day.
What is Positron's market cap?
Positron was worth $55.84M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is POSC's P/E ratio?
Positron lost money over fiscal 2025 (diluted EPS -$0.34), so it has no meaningful P/E ratio.
How much revenue does Positron make?
Positron reported revenue of $461.45K for fiscal 2025, down 21.5% from a year earlier.
Does Positron pay a dividend?
No. Positron has not paid a cash dividend over the last twelve months.
How has POSC stock performed over the past year?
Including dividends, POSC returned +22.9% over the past year, against +16.6% for the S&P 500.
Who are Positron's competitors?
Companies most similar to Positron by business, industry and size include GTHP, ITOC, NXL, ADMT, QTEX.
See a number that looks wrong?